Raymond James Financial Inc Merck & Co., Inc. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 7,637,165 shares of MRK stock, worth $613 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
7,637,165
Previous 15,640,892
51.17%
Holding current value
$613 Million
Previous $1.4 Billion
56.94%
% of portfolio
0.22%
Previous 0.54%
Shares
3 transactions
Others Institutions Holding MRK
# of Institutions
3,828Shares Held
1.95BCall Options Held
28.3MPut Options Held
29.6M-
Vanguard Group Inc Valley Forge, PA253MShares$20.3 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$9.52 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.17 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.73 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $203B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...